A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial]
Top Cited Papers
- 20 April 2022
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 77 (3) , 670-682
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Fluid management in sepsis: The potential beneficial effects of albuminJournal of Critical Care, 2016
- Developing a New Definition and Assessing New Clinical Criteria for Septic ShockJAMA, 2016
- Gas exchange and ventilation–perfusion relationships in the lungEuropean Respiratory Journal, 2014
- Albumin Replacement in Patients with Severe Sepsis or Septic ShockNew England Journal of Medicine, 2014
- Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanismsHepatology, 2012
- Intensive care of the patient with cirrhosisHepatology, 2011
- The role of albumin as a resuscitation fluid for patients with sepsis: A systematic review and meta-analysis*Critical Care Medicine, 2011
- EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosisJournal of Hepatology, 2010
- A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care UnitNew England Journal of Medicine, 2004
- Septic shock in patients with cirrhosisCritical Care Medicine, 1992